Del. Justices Undo Insurance Cap Ruling In Alexion Suit

Delaware's top court has reversed a Superior Court ruling that upheld Alexion Pharmaceuticals' claim to coverage under a $105 million "tower" of insurance for potential stockholder claims in a suit accusing...

Already a subscriber? Click here to view full article